
Keywords: 5â² UTR; 5â² untranslated region; 3â² UTR; 3â² untranslated region; ALPL; alkaline phosphatase liver-type; AP; alkaline phosphatase; CKD; chronic kidney disease; DNE; dominant negative effect; ECM; extracellular matrix; ERT; enzyme replacement therapy